Bingya Liu Selected Research

Zinc Finger Protein GLI1

4/2017	GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
1/2014	MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingya Liu Research Topics

Disease

72	Stomach Neoplasms (Stomach Cancer) 10/2021 - 09/2004
67	Neoplasms (Cancer) 10/2021 - 09/2004
25	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2011
10	Carcinogenesis 07/2017 - 12/2010
6	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 12/2012
6	Breast Neoplasms (Breast Cancer) 01/2014 - 05/2010
4	Carcinoma (Carcinomatosis) 01/2020 - 05/2009
4	Lymphatic Metastasis 02/2018 - 02/2012
4	Colonic Neoplasms (Colon Cancer) 01/2015 - 09/2010
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2015
2	Residual Neoplasm 08/2017 - 04/2017
2	Laryngeal Neoplasms (Laryngeal Cancer) 08/2016 - 11/2011
2	Infections 10/2012 - 03/2011
2	Chromosomal Instability (Chromosome Stability) 02/2012 - 11/2011
1	Ascites 01/2021
1	Metaplasia 01/2020
1	Endotoxemia 01/2019
1	Sepsis (Septicemia) 01/2019

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 07/2021 - 02/2007
20	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2007
12	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2010
11	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 09/2010
8	Biological ProductsIBA 01/2019 - 07/2010
8	Small Interfering RNA (siRNA)IBA 08/2017 - 05/2010
6	Long Noncoding RNAIBA 01/2021 - 04/2014
6	Messenger RNA (mRNA)IBA 07/2017 - 12/2011
5	CateninsIBA 02/2019 - 10/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2011
3	Pharmaceutical PreparationsIBA 10/2021 - 04/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 07/2013
3	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 04/2015
3	Histones (Histone)IBA 07/2015 - 09/2008
3	AgarIBA 02/2014 - 06/2012
2	CytokinesIBA 01/2020 - 05/2012
2	Indicators and Reagents (Reagents)IBA 01/2018 - 04/2017
2	Zinc Finger Protein GLI1IBA 04/2017 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 09/2013
2	Neutralizing AntibodiesIBA 03/2017 - 07/2013
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2017 - 05/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 05/2015
2	Cell Adhesion MoleculesIBA 01/2017 - 04/2014
2	Carcinoembryonic AntigenIBA 01/2017 - 04/2014
2	Aurora Kinase AIBA 08/2016 - 11/2011
2	RNA (Ribonucleic Acid)IBA 03/2016 - 06/2010
2	ProteomeIBA 02/2016 - 02/2007
2	PaxillinIBA 05/2015 - 05/2014
2	Capecitabine (Xeloda)FDA Link 04/2015 - 07/2014
2	Claudin-1IBA 01/2015 - 04/2014
2	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 01/2015 - 09/2010
2	Blood Proteins (Serum Proteins)IBA 04/2014 - 09/2008
2	matrigelIBA 02/2014 - 01/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2013 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 09/2013 - 05/2010
2	ThioredoxinsIBA 12/2012 - 01/2011
2	Protein Tyrosine PhosphatasesIBA 06/2012 - 07/2010
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 06/2012 - 07/2010
2	AntigensIBA 05/2012 - 09/2004
2	Protein Isoforms (Isoforms)IBA 08/2011 - 05/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2011 - 06/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2021
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	anlotinibIBA 10/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2021
1	AutoantibodiesIBA 01/2021
1	VimentinIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 11/2020
1	Leucovorin (Folinic Acid)FDA Link 11/2020
1	Cytidine Diphosphate (CDP)IBA 11/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2020
1	Vascular Endothelial Growth Factor DIBA 11/2020
1	Cathepsin LIBA 11/2020
1	MucinsIBA 01/2020
1	spasmolytic polypeptideIBA 01/2020
1	PalmitatesIBA 02/2019
1	AcidsIBA 02/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2019
1	Cell Surface ReceptorsIBA 02/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	AMP-Activated Protein KinasesIBA 01/2019
1	PlatinumIBA 01/2019
1	Oncostatin MIBA 01/2019
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 01/2019
1	CRKL proteinIBA 01/2019
1	KinesinsIBA 01/2019
1	Thrombin FDA Link 01/2018
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2018
1	DisintegrinsIBA 04/2017
1	Metalloproteases (Metalloproteinases)IBA 04/2017
1	Janus Kinase 2IBA 03/2017
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2017
1	Interleukin-6 (Interleukin 6)IBA 03/2017

Therapy/Procedure

13	Therapeutics 01/2019 - 09/2004
10	Drug Therapy (Chemotherapy) 01/2019 - 06/2010
2	Immunotherapy 01/2015 - 09/2004
1	Neoadjuvant Therapy 11/2020